<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03050723</url>
  </required_header>
  <id_info>
    <org_study_id>CPH-401-201259</org_study_id>
    <nct_id>NCT03050723</nct_id>
  </id_info>
  <brief_title>Safety and Performance of Princess® FILLER for the Treatment of Facial Lipoatrophy, Asymmetry or Scars</brief_title>
  <acronym>FLASH 1</acronym>
  <official_title>A Prospective, Open-label, Non-comparative, Multicentre, Post-market Clinical Follow-up Study of the Princess® FILLER Performance and Safety for Correction of Facial Lipoatrophy, Morphological Asymmetry of the Face, or Debilitating Scars</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Croma-Pharma GmbH</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Croma-Pharma GmbH</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      In this study, eligible patients with the medical indications (facial lipoatrophy,
      morphological asymmetry of the face, or debilitating scars) will be treated with Princess®
      FILLER, and then will return for follow-up assessments 2, 4 and 24 weeks after the treatment.
      A touch-up treatment may be done 2 weeks after the treatment.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">November 20, 2016</start_date>
  <completion_date type="Actual">January 16, 2018</completion_date>
  <primary_completion_date type="Actual">July 17, 2017</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <intervention_model>Single Group Assignment</intervention_model>
    <intervention_model_description>Princess® FILLER</intervention_model_description>
    <primary_purpose>Other</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>6-point scale for clinical response</measure>
    <time_frame>Week 4</time_frame>
    <description>The proportion of patients with successful treatment outcome at the Week 4 visit based on the Investigator's opinion, where success is defined as excellent, good, or moderate correction of the defect</description>
  </primary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Actual">53</enrollment>
  <condition>Facial Lipoatrophy</condition>
  <condition>Morphological Asymmetry of the Face</condition>
  <condition>Debilitating Scars</condition>
  <arm_group>
    <arm_group_label>Princess® FILLER</arm_group_label>
    <arm_group_type>Other</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Princess® FILLER</intervention_name>
    <description>Princess® FILLER injections up to 10 ml applied to the eligible subjects at the baseline visit, and the touch-up visit, if applicable.</description>
    <arm_group_label>Princess® FILLER</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Male or female 18 years of age or older.

          -  Presence of a defect, which in the opinion of the Investigator can be corrected by a
             dermal filler, and is caused by: ° Facial lipoatrophy of moderate severity, or

               -  Morphological asymmetry of the face, or

               -  One or more debilitating scars on the face.

          -  Willingness to abstain from any cosmetic or surgical procedures in the treatment area
             for the duration of the clinical investigation.

          -  Willingness to take part in the clinical investigation as evidenced by a personally
             signed informed consent.

        Exclusion Criteria:

          -  Pregnancy, breastfeeding, or unwillingness to use contraception throughout the
             clinical investigation (for women of child-bearing potential only).

          -  History of allergic reaction or hypersensitivity to hyaluronic acid.

          -  History or presence of any autoimmune or connective tissue disease, or current
             treatment with immune therapy.

          -  Presence of silicone implant or other non-absorbable tissue filler in the area
             targeted for intervention, or pre-treatment with any hyaluronic acid filler within the
             last 6 months.

          -  Presence of infectious, inflammatory, or proliferative lesions in the area targeted
             for intervention.

          -  Treatment with anticoagulant or antiplatelet drugs

          -  Any disease or condition which, in the Investigator's opinion, represents a safety
             risk for participation in the study

          -  Current participation in another clinical trial, or previous treatment with any
             investigational drug/device within 30 days prior to enrolment

          -  Institutionalized persons with legally limited civil rights
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Daisy Kopera, Prof.</last_name>
    <role>Principal Investigator</role>
    <affiliation>Medical University Graz, Austria</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Medical University Graz</name>
      <address>
        <city>Graz</city>
        <country>Austria</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>MÄZ WIEN (Medizinisch Ästhetisches Zentrum Wien)</name>
      <address>
        <city>Wien</city>
        <country>Austria</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Ordination Dr. Benjamin Gehl</name>
      <address>
        <city>Wien</city>
        <country>Austria</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Austria</country>
  </location_countries>
  <verification_date>January 2018</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>February 9, 2017</study_first_submitted>
  <study_first_submitted_qc>February 9, 2017</study_first_submitted_qc>
  <study_first_posted type="Actual">February 13, 2017</study_first_posted>
  <last_update_submitted>January 23, 2018</last_update_submitted>
  <last_update_submitted_qc>January 23, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">January 25, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Facies</mesh_term>
    <mesh_term>Lipodystrophy</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

